Shilpa Biocare, a wholly owned subsidiary of Shilpa Medicare, has signed a commercial supply agreement with Finland-based Orion Corporation for its recombinant human albumin. The agreement, announced ahead of the BIO International Convention in Boston, US, grants Orion exclusive rights to distribute, market and sell the product across Europe. Recombinant human Aabumin is a synthetic […]
The post Shilpa Medicare and Orion partner, expanding into European market appeared first on Pharmafile.
